The U.S. female external catheter market size was estimated at USD 442.65 million in 2024 and is projected to reach USD 807.43 million by 2033, growing at a CAGR of 7.09% from 2025 to 2033. The market growth is driven by the rising prevalence of urinary incontinence among women, especially in the aging population, increasing awareness and adoption of non-invasive urinary management solutions, and the growing demand for improved hygiene and comfort in long-term care and hospital settings.
In addition, the shift toward home healthcare services and advancements in female external catheter design further fuel market growth. According to the Vintage 2024 Population Estimates released by the U.S. Census Bureau, in 2024, women accounted for 50.5% of the total U.S. population, overtaking the number of men by approximately 3.4 million.
The increasing prevalence of chronic health conditions, particularly diabetes and ovarian cancer, is anticipated to significantly contribute to the growing demand for female external catheters in the U.S. These conditions are associated with urinary complications, such as bladder dysfunction or incontinence, which require non-invasive and patient-friendly management solutions to maintain comfort, hygiene, and quality of life, especially in elderly and chronically ill patients. According to data published in August 2024 by Diabetes, Obesity, and Metabolism, approximately 96 million U.S. adults are living with prediabetes, while an additional 37 million individuals have been diagnosed with diabetes. The prevalence of diabetes among females stood at 11.56% in 2022, highlighting a substantial burden on the female population.
Furthermore, ovarian cancer remains a critical health issue among U.S. women, with rising case numbers projected over the coming decades. This form of cancer can also lead to urinary dysfunctions, particularly after surgery or treatment, further increasing the need for supportive urinary care products such as female external catheters.
In addition, the shift toward home healthcare services and advancements in female external catheter design further fuel market growth. According to the Vintage 2024 Population Estimates released by the U.S. Census Bureau, in 2024, women accounted for 50.5% of the total U.S. population, overtaking the number of men by approximately 3.4 million.
The increasing prevalence of chronic health conditions, particularly diabetes and ovarian cancer, is anticipated to significantly contribute to the growing demand for female external catheters in the U.S. These conditions are associated with urinary complications, such as bladder dysfunction or incontinence, which require non-invasive and patient-friendly management solutions to maintain comfort, hygiene, and quality of life, especially in elderly and chronically ill patients. According to data published in August 2024 by Diabetes, Obesity, and Metabolism, approximately 96 million U.S. adults are living with prediabetes, while an additional 37 million individuals have been diagnosed with diabetes. The prevalence of diabetes among females stood at 11.56% in 2022, highlighting a substantial burden on the female population.
Furthermore, ovarian cancer remains a critical health issue among U.S. women, with rising case numbers projected over the coming decades. This form of cancer can also lead to urinary dysfunctions, particularly after surgery or treatment, further increasing the need for supportive urinary care products such as female external catheters.
U.S. Female External Catheter Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. female external catheter market report based on application, area of incontinence, and end use:Application Outlook (Revenue, USD Million, 2021 - 2033)
- Strokes
- Alzheimer's Disease
- Spinal Cord Injury
- Parkinson's Disease
- Multiple Sclerosis
- Bladder Cancer
- Ovarian Cancer
- Diabetes
- Others
Area of Incontinence Outlook (Revenue, USD Million, 2021 - 2033)
- Functional
- Urge/OAB
- Severe Incontinence
- Mixed
- Stress Urinary Incontinence
- Overflow
- Reflex
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Home Care
- Hospitals
- Other
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Female External Catheter Market Variables, Trends, & Scope
Chapter 4. U.S. Female External Catheter Market: Application Estimates & Trend Analysis
Chapter 5. U.S. Female External Catheter Market: Area of Incontinence Estimates & Trend Analysis
Chapter 6. U.S. Female External Catheter Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Stryker
- BD (Becton, Dickinson & Corporation)
- Medline Industries, LP.
- Boehringer Laboratories, LLC.
- Consure Medical
- Ur24Technology, Inc.
- TillaCare Ltd.
